Larvol Delta - ADCED01-recently-received-Orphan-Drug-Designation-ODD-from-the-US-FDA-for-the-treatment-of-soft-tissue-sarcoma

ADCE-D01 - Adcendo

https://www.prnewswire.com/news-releases/adcendo-aps-provides-updates-on-pipeline-progress-and-recent-achievements-for-its-first--and-best-in-class-antibody-drug-conjugates-302746438.html

Apr 20, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next